[Modification of the endometrium during combined therapy with dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17-n-butyrate].
D000328:Adult; D000463:Algestone Acetophenide / Q000494:pharmacology*; D004338:Drug Combinations; D004717:Endometrium / Q000187:drug effects*; D004958:Estradiol / Q000494:pharmacology*; D004967:Estrogens / Q000652:urine; D005260:Female; D006801:Humans; D008593:Menopause; D008598:Menstruation; D008875:Middle Aged; D011276:Pregnanediol / Q000652:urine
D004338:Drug Combinations; D004967:Estrogens; D004958:Estradiol; D011276:Pregnanediol; D000463:Algestone Acetophenide
Modificazioni endometriali durante trattamento con l'associazione di diidrossiprogesterone acetofenide ed estradiolo-3-benzoato-17-n-butirrato